IPO Pipeline Overview - As of July 27, there are 305 companies in the IPO pipeline, with 30 on the Shanghai Main Board, 36 on the Sci-Tech Innovation Board, 26 on the Shenzhen Main Board, 30 on the Growth Enterprise Market, and 183 on the Beijing Stock Exchange [2] - The total number of companies at various stages includes 24 accepted, 223 under inquiry, 12 approved, 27 suspended, and 19 registered [3] Newly Listed Companies - During the period from July 21 to July 27, two companies were newly listed: Shandong Shanda Electric Power Technology Co., Ltd. on the Growth Enterprise Market and Jiyuan Group Co., Ltd. on the Shanghai Main Board [4] - Shandong Shanda Electric Power Technology Co., Ltd. closed at 66.85 CNY per share, with a surge of 356.00% and a trading volume of 22.22 billion CNY, achieving a turnover rate of 82.61% [4][6] - Jiyuan Group Co., Ltd. closed at 40.75 CNY per share, with an increase of 274.54% and a trading volume of 13.72 billion CNY, achieving a turnover rate of 80.75% [6] New Counseling Record Companies - Six companies were newly recorded for counseling from July 21 to July 27, including Guangde Tianyun New Technology Co., Ltd. and Beijing Yingshirui Technology Co., Ltd. [7] - Guangde Tianyun New Technology Co., Ltd. focuses on the development, production, and sales of automotive sunroofs and interior components [8] - Beijing Yingshirui Technology Co., Ltd. integrates advanced cloud computing and AI technologies to provide digital service solutions for environmental monitoring [8] CSRC Review Status - Qingdao Taikaiying Special Tire Co., Ltd. successfully passed the review, while Xiamen Hengkang New Materials Technology Co., Ltd. was postponed [10] - Qingdao Taikaiying specializes in the design, research, sales, and service of tires for the mining and construction industries [12] CSRC Registration Approval - Three companies received registration approval from July 21 to July 27: Ningbo Nengzhiguang New Materials Technology Co., Ltd., Shanghai Balanshi Automotive Testing Equipment Co., Ltd., and Beijing Haochuang Ruitong Electric Equipment Co., Ltd. [14] - Ningbo Nengzhiguang focuses on the research, production, and sales of polymer additives and functional polymer materials [16] - Shanghai Balanshi specializes in automotive maintenance and testing equipment [17] Termination of Review - No companies withdrew from the review process during the period from July 21 to July 27 [20]

AI and Market Trends - AI applications are entering a rapid growth phase, supported by mature infrastructure and decreasing costs of large model calls, enhancing commercial potential[3] - China possesses significant data reserves and a broad demand scale, providing a competitive advantage for AI development[3] Market Performance - The A-share market experienced a general rise, with the Shanghai Composite Index up by 1.67% and the Shenzhen Component Index up by 2.33% during the week[15] - Mid-cap indices such as the CSI 500 and CSI 1000 outperformed large-cap indices, with increases of 3.28% and 2.38% respectively[17] Dietary Supplements Industry - The global dietary supplement market is projected to reach $223 billion by 2026, driven by population growth and increasing health awareness[5] - HMB, a key nutrient for muscle health, is expected to see global production reach 3,572 tons by 2030, indicating strong market potential[5] Investment Recommendations - Recommended stocks include Toris (拓尔思), which has a robust open-source intelligence data resource, and Songlin Technology (松霖科技), focusing on health robots[3] - Other notable mentions are Rongxin Culture (荣信文化), which is expanding into AI+ education scenarios[3] Corporate Actions - This week, two companies listed on the A-share market, with C Shanda and C Jiyuan seeing first-day gains of 356% and 274% respectively[33] - There were six new public offerings announced, with an average discount rate of 18.9% and an average return of 40.7% on recent fundraising projects[34][40]

Core Viewpoint - The article provides an overview of the latest trends in investment and financing activities in the domestic market, highlighting key sectors, regional distributions, and significant financing events. Group 1: Investment Overview - This week, there were 89 disclosed financing events in the domestic primary market, a decrease of 37 events compared to the previous week. The total disclosed financing amount was 7.181 billion RMB, with an average financing amount of 189 million RMB [5]. - The most active sectors in terms of financing events were smart manufacturing (22 events), healthcare (16 events), and artificial intelligence (16 events) [7]. Group 2: Sector Analysis - In terms of disclosed financing amounts, the artificial intelligence sector led with a total financing scale of approximately 2.480 billion RMB. Notably, "Zhongqing Robot," a developer of general-purpose humanoid robots, completed nearly 1 billion RMB in Series A financing [8]. - The healthcare sector followed with a disclosed financing total of 2.069 billion RMB. "Tongxin Medical," a developer of artificial heart assist devices, completed a financing round exceeding 100 million USD [9]. Group 3: Regional Distribution - The disclosed financing events were primarily concentrated in Shanghai (19 events), Jiangsu (18 events), and Beijing (12 events) [13]. Group 4: Stage Distribution - The stage distribution of the disclosed financing events included 64 early-stage, 19 growth-stage, and 6 late-stage events [16]. Group 5: Major Financing Events - The article highlights significant financing events, including the acquisition of a 23.4% stake in "Zhongying Electronics," a single-chip integrated circuit design developer, by "Zhineng Electronics" for 1.245 billion RMB [37].

Market Overview - As of July 25, the Shanghai Composite Index closed at 3593.66 points, down 12.07 points, a decrease of 0.33% [1] - The Shenzhen Component Index closed at 11168.14 points, down 24.92 points, a decrease of 0.22% [1] - The ChiNext Index closed at 2340.06 points, down 5.31 points, a decrease of 0.23% [1] Trading Activity - A total of 89 A-shares had a turnover rate exceeding 20% on this day [1] - Notable stocks with high turnover rates included: - C Jiyuan with a turnover rate of 54.05% and a closing price of 39.11 yuan, up 1.14% [1] - Nanfang Luji with a turnover rate of 53.88% and a closing price of 37.47 yuan, down 1.99% [1] - C Shanda with a turnover rate of 46.70% and a closing price of 56.34 yuan, down 7.32% [1] - Xizang Tianlu with a turnover rate of 45.81% and a closing price of 15.43 yuan, up 9.98% [1] Notable Stocks - Other stocks with significant turnover rates included: - Kangzhi Pharmaceutical with a turnover rate of 43.46% and a closing price of 7.61 yuan, up 0.66% [1] - Tianrun Technology with a turnover rate of 42.98% and a closing price of 32.76 yuan, up 30.00% [1] - Tietuo Machinery with a turnover rate of 40.09% and a closing price of 30.45 yuan, up 5.58% [1] - Stocks with notable declines included: - Shenong Agriculture with a turnover rate of 39.57% and a closing price of 4.94 yuan, down 9.69% [1] - Han Jian Heshan with a turnover rate of 38.93% and a closing price of 5.95 yuan, down 9.98% [1]

Core Insights - The company has over 20 years of experience in the global dietary supplement industry, focusing on scientific research and clinical trials to provide innovative and customized nutritional ingredients and formulations [1] - In 2024, the company achieved a revenue of 1.002 billion yuan, representing a year-on-year growth of 12.33% [1] Industry Overview - The global dietary supplement market exceeded $187 billion in 2023 and is expected to maintain a steady growth rate of 6% over the next three years, reaching $223 billion by 2026 [2] - The company operates as both a nutritional ingredient supplier and a formulation manufacturer, with strong competitiveness in HMB, glucosamine, and other nutritional ingredients [2] Product Segmentation - **HMB**: The company holds over 50% of the global market share and is a key player in the HMB industry, collaborating with major companies like Metabolic and Abbott to drive HMB commercialization [2] - **Glucosamine**: The company is a leading provider of high-quality glucosamine, achieving a stable global market share of 12.61% in 2024 [3] - **Other Nutritional Ingredients**: The company has enhanced its research capabilities through the strategic acquisition of Metabolic Technologies, focusing on new ingredient development [3] - **Formulation Business**: The company emphasizes innovative dosage forms and has obtained TGA GMP certification for its production facility, enabling it to offer personalized nutritional solutions [4] Financial Projections - The company is expected to achieve revenues of 1.184 billion yuan, 1.436 billion yuan, and 1.758 billion yuan from 2025 to 2027, with year-on-year growth rates of 18.2%, 21.2%, and 22.5% respectively [5] - Projected net profits for the same period are 199 million yuan, 239 million yuan, and 310 million yuan, with growth rates of 13.8%, 20.1%, and 30.1% respectively [5]

Group 1 - C Jiyuan (603262) saw a first-day increase of 274.54%, with a turnover rate of 80.75% and a transaction amount of 1.372 billion yuan [2] - The stock had a net inflow of 337 million yuan from major funds on its first trading day, with a net inflow of 123 million yuan from large orders and 215 million yuan from big orders [3] - The stock's first-day financing amount was 55.2954 million yuan, accounting for 4.03% of the total trading volume, with a latest financing balance of 51.4479 million yuan, representing 3.25% of the circulating market value [2][3] Group 2 - The company primarily engages in the research and development of dietary nutritional supplements and their industrialization [3] - On the first trading day, the top five trading departments on the dragon and tiger list had a total transaction amount of 195 million yuan, with a net purchase of 10.0034 million yuan [3]

本报讯 （记者李亚男）7月23日，技源集团股份有限公司（简称"技源集团"）正式登陆上交所主板。公 司上市首日高开368.75%，截至收盘，股价报收40.75元/股。 技源集团主营业务为膳食营养补充产品的研发创新及产业化，为全球HMB原料最大供应商和高品质氨 糖、制剂等产品核心供应商，是行业内少有的同时布局从营养素分子筛选及评估、功效研究、功能声称 及专利申请、市场准入与推广、原料生产到成品制剂加工的全产业链企业。 （编辑 郭之宸） 周京石表示："展望未来，我们将加速全球化布局，在中国香港、泰国、美国、欧洲建设产能，进一步 巩固和扩大在营养原料、营养制剂、精准和个性化营养方面的竞争优势，让'中国智造'的膳食营养补充 产品闪耀全球市场，用营养的力量提升全人类的健康水平。" 上市仪式现场，技源集团创始人、董事长周京石表示："技源集团深耕全球膳食营养补充行业二十余 载，始终坚持以持续创新和全球化发展为核心驱动力。目前，公司拥有国内外发明专利228项，建立了 从创新营养素分子筛选、功效研究、原料到成品制剂生产、配方开发到创新产品全案交付的全链路能 力，服务于全球范围内超过800家客户。" 据了解，HMB可以双向调节肌肉 ...

具体来看，今日上榜的营业部中，共有5家机构专用席位现身，即卖一、卖二、卖三、卖四、卖五，合 计净卖出9260.73万元。 资金流向方面，今日该股主力资金净流入3.37亿元，其中，特大单净流入1.23亿元，大单资金净流入 2.15亿元。近5日主力资金净流入3.37亿元。 7月4日公司发布的一季报数据显示，一季度公司共实现营业收入2.65亿元，同比增长16.59%，实现净利 润4260.17万元，同比增长9.25%。 7月22日公司发布上半年业绩预告，预计实现净利润1.02亿元至1.12亿元，同比变动区间为 8.56%~19.20%。（数据宝） C技源7月23日交易公开信息 C技源(603262)今日上涨274.54%，全天换手率80.75%，成交额13.72亿元，振幅27.93%。龙虎榜数据显 示，机构净卖出9260.73万元，营业部席位合计净买入1.03亿元。 上交所公开信息显示，当日该股因无价格涨跌幅限制上榜，机构专用席位净卖出9260.73万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.95亿元，其中，买入成交额为1.03亿 元，卖出成交额为9260.73万元，合计净买入1000.34 ...

Core Viewpoint - TSI Group Co., Ltd. (referred to as "TSI Group") successfully listed on the Shanghai Stock Exchange, with a closing price of 40.75 yuan, representing a significant increase of 274.54% and a total market capitalization of 16.3 billion yuan [1] Company Overview - TSI Group specializes in the research, innovation, and industrialization of dietary nutritional supplements, positioning itself as an international enterprise group [1] - Prior to the issuance, TSI Hong Kong held 27,567.38 million shares, accounting for 78.76% of the total share capital, and remains the controlling shareholder post-issuance with a reduced stake of 68.92% [1] Shareholding Structure - The actual controllers, Zhou Jingshi and Long Ling, held 58.91% and 62.82% of TSI Group and TSI Holdings respectively, controlling a total of 84.47% voting rights before the issuance [2] - Post-issuance, the couple controls 73.91% of the voting rights, maintaining their status as actual controllers [2] Financial Performance - In 2022, 2023, and 2024, the company's operating revenues were 947.24 million yuan, 891.89 million yuan, and 1 billion yuan respectively, with net profits of 143.61 million yuan, 160.51 million yuan, and 175.34 million yuan [5] - The total assets as of December 31 for 2022, 2023, and 2024 were 924.46 million yuan, 1.02 billion yuan, and 1.19 billion yuan respectively, with a decreasing debt ratio from 34.30% to 20.23% [6] Fundraising and Project Allocation - The total number of shares issued was 50.01 million at a price of 10.88 yuan per share, raising a total of 54.41 million yuan, with a net amount of 47.98 million yuan after expenses [3] - The planned allocation of raised funds includes projects for the construction of a nutritional health raw material production base, expansion of production lines, and a technology innovation center, totaling 602.73 million yuan [4] Customer Dependency - TSI Group is the preferred supplier of HMB nutritional raw materials for Abbott Group, with sales to Abbott accounting for 23.44%, 17.38%, and 19.44% of the main business income in the reporting periods [10]

Market Overview - The A-share market experienced a rally on July 23, with the Shanghai Composite Index rising 0.75% to 3608.58 points, the Shenzhen Component Index increasing by 0.31% to 11134.07 points, and the ChiNext Index up by 0.72% to 2327.48 points [1][2]. Financial Sector Performance - The financial sector showed significant strength, with brokerage stocks experiencing notable gains. Guosheng Financial Holdings hit the daily limit, while Guosen Securities, Harbin Investment, and Bank of China Securities all rose over 5% [5][8]. - Other financial stocks such as China Pacific Insurance, Agricultural Bank of China, and Qilu Bank also saw increases exceeding 3% [8]. CRO Sector Activity - The Contract Research Organization (CRO) sector saw a surge, with stocks like Zhaoyan New Drug hitting the daily limit and companies such as Medisino, Boteng Co., and Haoyuan Pharmaceutical rising over 5% [10][11]. - Analysts from Zhongtai Securities noted that leading CRO and CDMO companies reported better-than-expected mid-year results, indicating a recovery in demand and potential for profit and valuation increases [11]. New Stock Listings - Two new stocks were listed on July 23, with Shanda Electric experiencing a dramatic rise of over 500% shortly after its debut. The company issued 40.72 million shares at an initial price of 14.66 yuan per share [13][14]. - Another new listing, Jiyuan Group, saw its shares increase by over 370%, with a current market capitalization of 16.6 billion yuan [15][16].